The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Betahistine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Betahistine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Betahistine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cerebral Thrombosis accounting for % of the Betahistine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 8mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Betahistine include TOWA PHARMACEUTICAL CO., LTD, Nichi-Iko Pharmaceutical, Takeda Pharmaceutical Company Limited, EA Pharma Co., Ltd., and Disphar International B.V., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Betahistine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
8mg
25mg
Others
Market segment by Application can be divided into
Cerebral Thrombosis
Cerebral Embolism
Others
The key market players for global Betahistine market are listed below:
TOWA PHARMACEUTICAL CO., LTD
Nichi-Iko Pharmaceutical
Takeda Pharmaceutical Company Limited
EA Pharma Co., Ltd.
Disphar International B.V.
HENNIG ARZNEIMITTEL GmbH & Co. KG
DOC Generici
Ciclum Farma Unipessoal
Mylan
Orion Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Betahistine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Betahistine, with price, sales, revenue and global market share of Betahistine from 2019 to 2022.
Chapter 3, the Betahistine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Betahistine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Betahistine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Betahistine.
Chapter 13, 14, and 15, to describe Betahistine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Betahistine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Betahistine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cerebral Thrombosis accounting for % of the Betahistine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 8mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Betahistine include TOWA PHARMACEUTICAL CO., LTD, Nichi-Iko Pharmaceutical, Takeda Pharmaceutical Company Limited, EA Pharma Co., Ltd., and Disphar International B.V., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Betahistine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
8mg
25mg
Others
Market segment by Application can be divided into
Cerebral Thrombosis
Cerebral Embolism
Others
The key market players for global Betahistine market are listed below:
TOWA PHARMACEUTICAL CO., LTD
Nichi-Iko Pharmaceutical
Takeda Pharmaceutical Company Limited
EA Pharma Co., Ltd.
Disphar International B.V.
HENNIG ARZNEIMITTEL GmbH & Co. KG
DOC Generici
Ciclum Farma Unipessoal
Mylan
Orion Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Betahistine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Betahistine, with price, sales, revenue and global market share of Betahistine from 2019 to 2022.
Chapter 3, the Betahistine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Betahistine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Betahistine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Betahistine.
Chapter 13, 14, and 15, to describe Betahistine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Betahistine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Betahistine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 8mg
1.2.3 25mg
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Betahistine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cerebral Thrombosis
1.3.3 Cerebral Embolism
1.3.4 Others
1.4 Global Betahistine Market Size & Forecast
1.4.1 Global Betahistine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Betahistine Sales in Volume (2017-2028)
1.4.3 Global Betahistine Price (2017-2028)
1.5 Global Betahistine Production Capacity Analysis
1.5.1 Global Betahistine Total Production Capacity (2017-2028)
1.5.2 Global Betahistine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Betahistine Market Drivers
1.6.2 Betahistine Market Restraints
1.6.3 Betahistine Trends Analysis
2 Manufacturers Profiles
2.1 TOWA PHARMACEUTICAL CO., LTD
2.1.1 TOWA PHARMACEUTICAL CO., LTD Details
2.1.2 TOWA PHARMACEUTICAL CO., LTD Major Business
2.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Product and Services
2.1.4 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Nichi-Iko Pharmaceutical
2.2.1 Nichi-Iko Pharmaceutical Details
2.2.2 Nichi-Iko Pharmaceutical Major Business
2.2.3 Nichi-Iko Pharmaceutical Betahistine Product and Services
2.2.4 Nichi-Iko Pharmaceutical Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Takeda Pharmaceutical Company Limited
2.3.1 Takeda Pharmaceutical Company Limited Details
2.3.2 Takeda Pharmaceutical Company Limited Major Business
2.3.3 Takeda Pharmaceutical Company Limited Betahistine Product and Services
2.3.4 Takeda Pharmaceutical Company Limited Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 EA Pharma Co., Ltd.
2.4.1 EA Pharma Co., Ltd. Details
2.4.2 EA Pharma Co., Ltd. Major Business
2.4.3 EA Pharma Co., Ltd. Betahistine Product and Services
2.4.4 EA Pharma Co., Ltd. Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Disphar International B.V.
2.5.1 Disphar International B.V. Details
2.5.2 Disphar International B.V. Major Business
2.5.3 Disphar International B.V. Betahistine Product and Services
2.5.4 Disphar International B.V. Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
2.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Details
2.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Major Business
2.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product and Services
2.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 DOC Generici
2.7.1 DOC Generici Details
2.7.2 DOC Generici Major Business
2.7.3 DOC Generici Betahistine Product and Services
2.7.4 DOC Generici Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ciclum Farma Unipessoal
2.8.1 Ciclum Farma Unipessoal Details
2.8.2 Ciclum Farma Unipessoal Major Business
2.8.3 Ciclum Farma Unipessoal Betahistine Product and Services
2.8.4 Ciclum Farma Unipessoal Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Betahistine Product and Services
2.9.4 Mylan Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Orion Corporation
2.10.1 Orion Corporation Details
2.10.2 Orion Corporation Major Business
2.10.3 Orion Corporation Betahistine Product and Services
2.10.4 Orion Corporation Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Betahistine Breakdown Data by Manufacturer
3.1 Global Betahistine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Betahistine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Betahistine
3.4 Market Concentration Rate
3.4.1 Top 3 Betahistine Manufacturer Market Share in 2021
3.4.2 Top 6 Betahistine Manufacturer Market Share in 2021
3.5 Global Betahistine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Betahistine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Betahistine Market Size by Region
4.1.1 Global Betahistine Sales in Volume by Region (2017-2028)
4.1.2 Global Betahistine Revenue by Region (2017-2028)
4.2 North America Betahistine Revenue (2017-2028)
4.3 Europe Betahistine Revenue (2017-2028)
4.4 Asia-Pacific Betahistine Revenue (2017-2028)
4.5 South America Betahistine Revenue (2017-2028)
4.6 Middle East and Africa Betahistine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Betahistine Sales in Volume by Type (2017-2028)
5.2 Global Betahistine Revenue by Type (2017-2028)
5.3 Global Betahistine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Betahistine Sales in Volume by Application (2017-2028)
6.2 Global Betahistine Revenue by Application (2017-2028)
6.3 Global Betahistine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Betahistine Sales by Type (2017-2028)
7.2 North America Betahistine Sales by Application (2017-2028)
7.3 North America Betahistine Market Size by Country
7.3.1 North America Betahistine Sales in Volume by Country (2017-2028)
7.3.2 North America Betahistine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Betahistine Sales by Type (2017-2028)
8.2 Europe Betahistine Sales by Application (2017-2028)
8.3 Europe Betahistine Market Size by Country
8.3.1 Europe Betahistine Sales in Volume by Country (2017-2028)
8.3.2 Europe Betahistine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Betahistine Sales by Type (2017-2028)
9.2 Asia-Pacific Betahistine Sales by Application (2017-2028)
9.3 Asia-Pacific Betahistine Market Size by Region
9.3.1 Asia-Pacific Betahistine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Betahistine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Betahistine Sales by Type (2017-2028)
10.2 South America Betahistine Sales by Application (2017-2028)
10.3 South America Betahistine Market Size by Country
10.3.1 South America Betahistine Sales in Volume by Country (2017-2028)
10.3.2 South America Betahistine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Betahistine Sales by Type (2017-2028)
11.2 Middle East & Africa Betahistine Sales by Application (2017-2028)
11.3 Middle East & Africa Betahistine Market Size by Country
11.3.1 Middle East & Africa Betahistine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Betahistine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Betahistine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Betahistine
12.3 Betahistine Production Process
12.4 Betahistine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Betahistine Typical Distributors
13.3 Betahistine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Betahistine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Betahistine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. TOWA PHARMACEUTICAL CO., LTD Basic Information, Manufacturing Base and Competitors
Table 4. TOWA PHARMACEUTICAL CO., LTD Major Business
Table 5. TOWA PHARMACEUTICAL CO., LTD Betahistine Product and Services
Table 6. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Nichi-Iko Pharmaceutical Major Business
Table 9. Nichi-Iko Pharmaceutical Betahistine Product and Services
Table 10. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Pharmaceutical Company Limited Major Business
Table 13. Takeda Pharmaceutical Company Limited Betahistine Product and Services
Table 14. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. EA Pharma Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. EA Pharma Co., Ltd. Major Business
Table 17. EA Pharma Co., Ltd. Betahistine Product and Services
Table 18. EA Pharma Co., Ltd. Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Disphar International B.V. Basic Information, Manufacturing Base and Competitors
Table 20. Disphar International B.V. Major Business
Table 21. Disphar International B.V. Betahistine Product and Services
Table 22. Disphar International B.V. Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. HENNIG ARZNEIMITTEL GmbH & Co. KG Basic Information, Manufacturing Base and Competitors
Table 24. HENNIG ARZNEIMITTEL GmbH & Co. KG Major Business
Table 25. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product and Services
Table 26. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. DOC Generici Basic Information, Manufacturing Base and Competitors
Table 28. DOC Generici Major Business
Table 29. DOC Generici Betahistine Product and Services
Table 30. DOC Generici Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Ciclum Farma Unipessoal Basic Information, Manufacturing Base and Competitors
Table 32. Ciclum Farma Unipessoal Major Business
Table 33. Ciclum Farma Unipessoal Betahistine Product and Services
Table 34. Ciclum Farma Unipessoal Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Mylan Basic Information, Manufacturing Base and Competitors
Table 36. Mylan Major Business
Table 37. Mylan Betahistine Product and Services
Table 38. Mylan Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 40. Orion Corporation Major Business
Table 41. Orion Corporation Betahistine Product and Services
Table 42. Orion Corporation Betahistine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Betahistine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Betahistine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Betahistine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Betahistine Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Betahistine Production Site of Key Manufacturer
Table 48. Betahistine New Entrant and Capacity Expansion Plans
Table 49. Betahistine Mergers & Acquisitions in the Past Five Years
Table 50. Global Betahistine Sales by Region (2017-2022) & (K Units)
Table 51. Global Betahistine Sales by Region (2023-2028) & (K Units)
Table 52. Global Betahistine Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Betahistine Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Betahistine Sales by Type (2017-2022) & (K Units)
Table 55. Global Betahistine Sales by Type (2023-2028) & (K Units)
Table 56. Global Betahistine Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Betahistine Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Betahistine Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Betahistine Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Betahistine Sales by Application (2017-2022) & (K Units)
Table 61. Global Betahistine Sales by Application (2023-2028) & (K Units)
Table 62. Global Betahistine Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Betahistine Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Betahistine Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Betahistine Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Betahistine Sales by Country (2017-2022) & (K Units)
Table 67. North America Betahistine Sales by Country (2023-2028) & (K Units)
Table 68. North America Betahistine Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Betahistine Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Betahistine Sales by Type (2017-2022) & (K Units)
Table 71. North America Betahistine Sales by Type (2023-2028) & (K Units)
Table 72. North America Betahistine Sales by Application (2017-2022) & (K Units)
Table 73. North America Betahistine Sales by Application (2023-2028) & (K Units)
Table 74. Europe Betahistine Sales by Country (2017-2022) & (K Units)
Table 75. Europe Betahistine Sales by Country (2023-2028) & (K Units)
Table 76. Europe Betahistine Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Betahistine Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Betahistine Sales by Type (2017-2022) & (K Units)
Table 79. Europe Betahistine Sales by Type (2023-2028) & (K Units)
Table 80. Europe Betahistine Sales by Application (2017-2022) & (K Units)
Table 81. Europe Betahistine Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Betahistine Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Betahistine Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Betahistine Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Betahistine Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Betahistine Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Betahistine Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Betahistine Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Betahistine Sales by Application (2023-2028) & (K Units)
Table 90. South America Betahistine Sales by Country (2017-2022) & (K Units)
Table 91. South America Betahistine Sales by Country (2023-2028) & (K Units)
Table 92. South America Betahistine Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Betahistine Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Betahistine Sales by Type (2017-2022) & (K Units)
Table 95. South America Betahistine Sales by Type (2023-2028) & (K Units)
Table 96. South America Betahistine Sales by Application (2017-2022) & (K Units)
Table 97. South America Betahistine Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Betahistine Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Betahistine Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Betahistine Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Betahistine Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Betahistine Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Betahistine Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Betahistine Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Betahistine Sales by Application (2023-2028) & (K Units)
Table 106. Betahistine Raw Material
Table 107. Key Manufacturers of Betahistine Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Betahistine Typical Distributors
Table 111. Betahistine Typical Customers
List of Figures
Figure 1. Betahistine Picture
Figure 2. Global Betahistine Revenue Market Share by Type in 2021
Figure 3. 8mg
Figure 4. 25mg
Figure 5. Others
Figure 6. Global Betahistine Revenue Market Share by Application in 2021
Figure 7. Cerebral Thrombosis
Figure 8. Cerebral Embolism
Figure 9. Others
Figure 10. Global Betahistine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Betahistine Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Betahistine Sales (2017-2028) & (K Units)
Figure 13. Global Betahistine Price (2017-2028) & (US$/Unit)
Figure 14. Global Betahistine Production Capacity (2017-2028) & (K Units)
Figure 15. Global Betahistine Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Betahistine Market Drivers
Figure 17. Betahistine Market Restraints
Figure 18. Betahistine Market Trends
Figure 19. Global Betahistine Sales Market Share by Manufacturer in 2021
Figure 20. Global Betahistine Revenue Market Share by Manufacturer in 2021
Figure 21. Betahistine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Betahistine Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Betahistine Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Betahistine Sales Market Share by Region (2017-2028)
Figure 25. Global Betahistine Revenue Market Share by Region (2017-2028)
Figure 26. North America Betahistine Revenue (2017-2028) & (USD Million)
Figure 27. Europe Betahistine Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Betahistine Revenue (2017-2028) & (USD Million)
Figure 29. South America Betahistine Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Betahistine Revenue (2017-2028) & (USD Million)
Figure 31. Global Betahistine Sales Market Share by Type (2017-2028)
Figure 32. Global Betahistine Revenue Market Share by Type (2017-2028)
Figure 33. Global Betahistine Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Betahistine Sales Market Share by Application (2017-2028)
Figure 35. Global Betahistine Revenue Market Share by Application (2017-2028)
Figure 36. Global Betahistine Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Betahistine Sales Market Share by Type (2017-2028)
Figure 38. North America Betahistine Sales Market Share by Application (2017-2028)
Figure 39. North America Betahistine Sales Market Share by Country (2017-2028)
Figure 40. North America Betahistine Revenue Market Share by Country (2017-2028)
Figure 41. United States Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Betahistine Sales Market Share by Type (2017-2028)
Figure 45. Europe Betahistine Sales Market Share by Application (2017-2028)
Figure 46. Europe Betahistine Sales Market Share by Country (2017-2028)
Figure 47. Europe Betahistine Revenue Market Share by Country (2017-2028)
Figure 48. Germany Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Betahistine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Betahistine Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Betahistine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Betahistine Revenue Market Share by Region (2017-2028)
Figure 57. China Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Betahistine Sales Market Share by Type (2017-2028)
Figure 64. South America Betahistine Sales Market Share by Application (2017-2028)
Figure 65. South America Betahistine Sales Market Share by Country (2017-2028)
Figure 66. South America Betahistine Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Betahistine Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Betahistine Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Betahistine Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Betahistine Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Betahistine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Betahistine in 2021
Figure 78. Manufacturing Process Analysis of Betahistine
Figure 79. Betahistine Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
